Advertisement

Advertisement

AYTU Stock Latest News

Aytu BioPharma reports Q4 EPS 0c, consensus (35c)

The FlyAytu BioPharma reports Q4 EPS 0c, consensus (35c)

AYTU Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

AYTU Earnings Report this Week: Is It a Buy, Ahead of Earnings?

7d ago

Aytu BioScience Bets on EXXUA Amid Legacy Declines

PremiumCompany Announcements

Aytu BioScience Bets on EXXUA Amid Legacy Declines

4M ago

Aytu BioScience Earnings Call: EXXUA Drives Transition

PremiumCompany Announcements

Aytu BioScience Earnings Call: EXXUA Drives Transition

4M ago

Aytu BioPharma reports Q3 EPS (53c), consensus (43c)

PremiumThe Fly

Aytu BioPharma reports Q3 EPS (53c), consensus (43c)

5M ago

AYTU Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-EarningsAYTU Earnings Report this Week: Is It a Buy, Ahead of Earnings?

5M ago

Aytu BioScience Amends Warrants, Modifying Security Holder Rights

Company Announcements

Aytu BioScience Amends Warrants, Modifying Security Holder Rights

6M ago

Aytu BioScience Earnings Call: ExuA Launch vs. Headwinds

Company Announcements

Aytu BioScience Earnings Call: ExuA Launch vs. Headwinds

8M ago

Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year

PremiumThe Fly

Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year

8M ago

Is AYTU a Buy, Before Earnings?

PremiumPre-Earnings

Is AYTU a Buy, Before Earnings?

8M ago

Aytu BioPharma Highlights EXXUA Opportunity at Investor Day

PremiumCompany Announcements

Aytu BioPharma Highlights EXXUA Opportunity at Investor Day

8M ago

Aytu BioPharma announces nationwide commercial launch of EXXUA

PremiumThe Fly

Aytu BioPharma announces nationwide commercial launch of EXXUA

8M ago

Aytu BioPharma announces commercial availability of EXXUA tablets

PremiumThe FlyAytu BioPharma announces commercial availability of EXXUA tablets

10M ago

Aytu BioScience Stockholders Approve Key Proposals

Company Announcements

Aytu BioScience Stockholders Approve Key Proposals

10M ago

Aytu BioScience Earnings Call Highlights Growth and Challenges

Company Announcements

Aytu BioScience Earnings Call Highlights Growth and Challenges

10M ago

Aytu BioScience: Strong Financial Performance and Strategic Initiatives Drive Buy Rating

PremiumRatings

Aytu BioScience: Strong Financial Performance and Strategic Initiatives Drive Buy Rating

11M ago

Aytu BioPharma Reports Q1 2026 Earnings and EXXUA Launch Plans

PremiumCompany Announcements

Aytu BioPharma Reports Q1 2026 Earnings and EXXUA Launch Plans

11M ago

Aytu BioScience (AYTU) Q1 Earnings Cheat Sheet

PremiumPre-Earnings

Aytu BioScience (AYTU) Q1 Earnings Cheat Sheet

11M ago

Aytu BioPharma announces patent term extension for EXXUA

PremiumThe Fly

Aytu BioPharma announces patent term extension for EXXUA

11M ago

Aytu BioPharma management to meet with Lake Street

PremiumThe FlyAytu BioPharma management to meet with Lake Street

12M ago

Aytu BioPharma price target lowered to $7 from $9 at Maxim

The Fly

Aytu BioPharma price target lowered to $7 from $9 at Maxim

1y ago

Aytu BioPharma’s Optimistic Earnings Call Highlights ExuA Launch

Company Announcements

Aytu BioPharma’s Optimistic Earnings Call Highlights ExuA Launch

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >